• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎:诊断与治疗综述

Atopic Dermatitis: A Review of Diagnosis and Treatment.

作者信息

Jeskey Jack, Kurien Christine, Blunk Henry, Sehmi Kiran, Areti Sathya, Nguyen Delena, Hostoffer Robert

机构信息

Department of Pulmonary & Critical Care, Allergy and Immunology Division, Case Western Reserve University/University Hospitals Cleveland Medical Center Program, Cleveland, OH.

出版信息

J Pediatr Pharmacol Ther. 2024 Dec;29(6):587-603. doi: 10.5863/1551-6776-29.6.587. Epub 2024 Dec 9.

DOI:10.5863/1551-6776-29.6.587
PMID:39659858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11627575/
Abstract

Atopic dermatitis, more commonly known as atopic eczema, is a chronic, relapsing inflammatory skin disorder characterized by dry skin, localized erythematous rash, and intense pruritus. The clinical manifestations are variable and age dependent. As one of the most common skin disorders globally, atopic dermatitis poses a significant clinical and economic burden on affected patients. Individual treatment strategies are imperative in improving patient outcomes and reducing these burdens. Recent advances in understanding the genetic, immunologic, and environmental factors influencing atopic dermatitis have opened avenues for novel treatment modalities. This article highlights the clinical presentation, pathophysiology, diagnosis criteria, as well as current recommendations on treatment of atopic dermatitis.

摘要

特应性皮炎,更常见的名称是特应性湿疹,是一种慢性复发性炎症性皮肤病,其特征为皮肤干燥、局限性红斑疹和剧烈瘙痒。临床表现多样且与年龄有关。作为全球最常见的皮肤疾病之一,特应性皮炎给受影响的患者带来了重大的临床和经济负担。个体化治疗策略对于改善患者预后和减轻这些负担至关重要。在理解影响特应性皮炎的遗传、免疫和环境因素方面的最新进展为新型治疗方式开辟了道路。本文重点介绍特应性皮炎的临床表现、病理生理学、诊断标准以及当前的治疗建议。

相似文献

1
Atopic Dermatitis: A Review of Diagnosis and Treatment.特应性皮炎:诊断与治疗综述
J Pediatr Pharmacol Ther. 2024 Dec;29(6):587-603. doi: 10.5863/1551-6776-29.6.587. Epub 2024 Dec 9.
2
Clinical Presentation of Atopic Dermatitis.特应性皮炎的临床表现。
Adv Exp Med Biol. 2017;1027:39-46. doi: 10.1007/978-3-319-64804-0_4.
3
Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis.特应性皮炎的更新:对特应性皮炎理解和治疗进展的综述。
Dis Mon. 2024 Apr;70(4):101687. doi: 10.1016/j.disamonth.2024.101687. Epub 2024 Jan 25.
4
Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.特应性皮炎的创新:从发病机制到治疗
Actas Dermosifiliogr (Engl Ed). 2020 Apr;111(3):205-221. doi: 10.1016/j.ad.2019.11.002. Epub 2020 Jan 20.
5
Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.特应性皮炎小鼠模型中牛痘样湿疹的诱导、治疗及预防
Vaccine. 2017 Jul 24;35(33):4245-4254. doi: 10.1016/j.vaccine.2017.06.014. Epub 2017 Jun 20.
6
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.阿布昔替尼、特利鲁单抗和乌帕替尼治疗中重度特应性皮炎。
Health Technol Assess. 2024 Jan;28(4):1-113. doi: 10.3310/LEXB9006.
7
Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments.特应性皮炎的免疫发病机制:重点关注细胞因子作为疾病驱动因子和新型治疗方法的治疗靶点。
Int J Mol Sci. 2023 Jan 2;24(1):781. doi: 10.3390/ijms24010781.
8
Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar.卡塔尔中重度特应性皮炎管理的专家意见。
J Dermatolog Treat. 2023 Dec;34(1):2251622. doi: 10.1080/09546634.2023.2251622.
9
Management of Severe Atopic Dermatitis in Pediatric Patients.儿童重症特应性皮炎的管理。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1462-1471. doi: 10.1016/j.jaip.2021.02.017.
10
Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.变应性和免疫性皮肤疾病中的生物制剂和小分子药物。
Curr Allergy Asthma Rep. 2018 Aug 31;18(10):55. doi: 10.1007/s11882-018-0804-8.

引用本文的文献

1
Vitamin D and Atopic Dermatitis-A Mere Correlation or a Real Supportive Treatment Option?维生素D与特应性皮炎——仅是一种关联还是一种切实可行的支持性治疗选择?
Nutrients. 2025 Aug 8;17(16):2582. doi: 10.3390/nu17162582.
2
Chitosan Nanoparticles Loaded with Polyphenols for Cosmeceutical Applications: A State-of-the-Art Review.负载多酚的壳聚糖纳米颗粒在药妆领域的应用:最新综述
Pharmaceutics. 2025 Aug 18;17(8):1068. doi: 10.3390/pharmaceutics17081068.
3
Atopic Dermatitis Management: from Conventional Therapies to Biomarker-Driven Treatment Approaches.特应性皮炎的管理:从传统疗法到生物标志物驱动的治疗方法。
Biomol Ther (Seoul). 2025 Sep 1;33(5):813-829. doi: 10.4062/biomolther.2025.081. Epub 2025 Aug 19.
4
Prevalence of Intolerance to Amines and Salicylates in Individuals with Atopic Dermatitis: A Systematic Review and Meta-Analysis.特应性皮炎患者对胺类和水杨酸盐不耐受的患病率:一项系统评价和荟萃分析。
Nutrients. 2025 May 9;17(10):1628. doi: 10.3390/nu17101628.

本文引用的文献

1
Bathing in Atopic Dermatitis in Pediatric Age: Why, How and When.小儿特应性皮炎的沐浴:原因、方法及时机
Pediatr Rep. 2024 Jan 8;16(1):57-68. doi: 10.3390/pediatric16010006.
2
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.特应性皮炎(湿疹)指南:2023 年美国过敏、哮喘和免疫学学会/美国过敏、哮喘和免疫学学会联合工作组关于实践参数的推荐意见,基于 GRADE 分级和医学研究所的建议。
Ann Allergy Asthma Immunol. 2024 Mar;132(3):274-312. doi: 10.1016/j.anai.2023.11.009. Epub 2023 Dec 18.
3
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.光疗和系统治疗成人特应性皮炎管理的指南。
J Am Acad Dermatol. 2024 Feb;90(2):e43-e56. doi: 10.1016/j.jaad.2023.08.102. Epub 2023 Nov 7.
4
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases: A Systematic Review and Meta-Analysis.免疫介导性炎症性皮肤病患者使用 JAK 抑制剂的心血管和静脉血栓栓塞风险:系统评价和荟萃分析。
JAMA Dermatol. 2024 Jan 1;160(1):28-36. doi: 10.1001/jamadermatol.2023.4090.
5
The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review.外用皮质类固醇激素治疗特应性皮炎的长期安全性:一项系统评价。
Skin Health Dis. 2023 Aug 16;3(5):e268. doi: 10.1002/ski2.268. eCollection 2023 Oct.
6
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.特应性皮炎(湿疹)的全身治疗:随机试验的系统评价和网状Meta分析
J Allergy Clin Immunol. 2023 Dec;152(6):1470-1492. doi: 10.1016/j.jaci.2023.08.029. Epub 2023 Sep 9.
7
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.特应性皮炎(湿疹)的局部治疗:随机试验的系统评价和网状荟萃分析
J Allergy Clin Immunol. 2023 Dec;152(6):1493-1519. doi: 10.1016/j.jaci.2023.08.030. Epub 2023 Sep 9.
8
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.在疾病活动度低的特应性皮炎患者中成功减少度普利尤单抗剂量:来自 BioDay 登记处的一项大型实用日常实践研究。
Br J Dermatol. 2023 Aug 24;189(3):327-335. doi: 10.1093/bjd/ljad159.
9
Atopic Dermatitis Yardstick update.特应性皮炎标准更新。
Ann Allergy Asthma Immunol. 2023 Jun;130(6):811-820. doi: 10.1016/j.anai.2023.03.010. Epub 2023 Mar 16.
10
Efficacy and Safety of Low-Dose Cyclosporine Relative to Immunomodulatory Drugs Used in Atopic Dermatitis: A Systematic Review and Meta-Analysis.低剂量环孢素相对于用于特应性皮炎的免疫调节药物的疗效和安全性:一项系统评价和荟萃分析
J Clin Med. 2023 Feb 9;12(4):1390. doi: 10.3390/jcm12041390.